| Abstrakt: |
A recent report from Kwansei Gakuin University in Japan discusses the potential use of statins, cholesterol-lowering drugs, for the treatment of melanoma. The researchers found that combining statins with an antiplatelet agent called dipyridamole resulted in a significant reduction in the growth of melanoma cells. In some cases, the combination treatment completely suppressed cell proliferation. The study also suggests that the combination therapy may enhance the effects of targeted therapy for melanoma patients with specific genetic mutations. These findings have the potential to lead to new developments in the treatment of melanoma. [Extracted from the article] |
